Federal grants to Artiam Bio Inc.
Artiam Bio Inc. in Cary, North Carolina received $1.2 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Alcohol Research Programs, with $368,673. In fiscal 2025 it was awarded $292,279.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$1.2 million
- Awards4
- Awarded in FY 2025$292,279
- Largest award$368,673
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $256,475 |
| FY 2022 | 1 | $319,898 |
| FY 2023 | 1 | $368,673 |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $292,279 |
Programs that fund Artiam Bio Inc.
| Program | Awards | Amount |
|---|---|---|
| Alcohol Research Programs | 1 | $368,673 |
| Drug Use and Addiction Research Programs | 1 | $319,898 |
| Aging Research | 1 | $292,279 |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $256,475 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $1.2 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Therapy for alcohol use disorder - abstract alcohol use disorder (AUD) is a major global health issue. In the us, aud affects over 14 million people over the age of 18. While there are three approved drugs for aud, less than 4% of patients eligible for pharmacotherapy are prescribed a medication – l | Alcohol Research Programs | September 20, 2023 | $368,673 |
| Treatment for cannabis use disorder - abstract our goal is to develop an innovative pharmacotherapy for cannabis use disorder (CUD) that affects over 4 million americans. We propose to develop a novel second generation partial inverse agonist of the cannabinoid 1 receptor (CB1) that has a benign beh | Drug Use and Addiction Research Programs | August 1, 2022 | $319,898 |
| Validation of APT101 for the treatment of systemic sclerosis-associated interstitial lung disease (ssc-ild) in an aging murine model - abstract systemic sclerosis (SSC) is a rare autoimmune disease which carries the highest risk of mortality of all connective tissue diseases. Two major subgroups of | Aging Research | September 19, 2025 | $292,279 |
| Therapeutic strategy for nash - abstract: therapeutic strategy for nash the overall goal of this project is to identify for clinical development a peripherally selective neutral antagonist of the CB1 receptor for non-alcoholic steatohepatitis (NASH). Non-alcoholic fatty liver disease (NAFLD) associa | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 20, 2021 | $256,475 |
Questions people ask
How much federal grant money does Artiam Bio Inc. get?
$1.2 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Artiam Bio Inc. the most?
The Department of Health and Human Services, with $1.2 million in 4 awards.
What is Artiam Bio Inc.'s largest federal grant?
$368,673 under Alcohol Research Programs, with its first action in the period on September 20, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Artiam Bio Inc.?
Its largest are Alcohol Research Programs, Drug Use and Addiction Research Programs and Aging Research.
Other grant recipients in Cary
- Wake County Public Schools
- Town of Cary
- Ncasi Foundation
- Focal Medical, Inc.
- Triad Math and Science Academy Company
- Selsym Biotech, Inc.
- Atom Bioworks Inc
- Epipointe LLC
Largest federal grant recipients in North Carolina · Federal grants in North Carolina